Legend Biotech Corp.
http://www.legendbiotech.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Legend Biotech Corp.
China Sets Clinical Trial Record But Starting Studies Can Be Challenging
Antibody-drug conjugates, GLP-1 receptor agonists and cell/gene therapies propelled a big increase in clinical trial registrations in China last year, but why do sponsors sometimes remain reluctant to actually start studies?
CAR-T Therapies: Access Considerations May Influence US FDA's Efficacy Evaluation
CBER's Lola Fashoyin-Aje offers some thoughts on when and how the FDA might consider the accessibility of a product in its approval decisions at BIO 2024.
Pfizer's Elrexfio Shows Long-Term OS, But Convenience Counts Too
The drug maker presented data from the pivotal Phase II trial at EHA showing median OS of more than two years for Elrexfio.
ASCO: Legend/J&J Explore Carvykti In Community
The companies presented data from CARTITUDE-4 in functional high-risk disease, which has a poorer prognosis, while they are also piloting a program to expand Carvykti’s geographic reach.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice